Amazon Botanicals

Herbs for Dry Skin

Price: $18.97
Description:
No messy creams - this product works from the inside out! Made from South American Samambaia - a natural herbal plant extract. In the 1970's extracts of Samambaia were reported to reduce the severity of psoriasis. Clinical research with double-blind placebo human trials over 3 months shows it to be effective for psoriasis, eczema and dermatitis. A safe natural treatment that has been proven to deliver results. Since only ethically harvested wildcrafted Samambaia is used in our product, we can ensure you the freshest Samambaia without fillers. Other companies may buy from a middle man that is selling stale or adulterated dry skin herbs without the vital energy found in fresh naturally grown Samambaia.

Samambaia a fern that grows in the South American rainforests. It is considered by the indigenous people of the Amazon rainforest to be a general psoriasis herb, eczema herb and dermatitis herb, to detoxify the body and to support the immune system. Toxicity studies on samambaia with mice and rats have shown no toxicity and in humans oral doses greater than 1,000 mg have not shown toxicity.1 In the mid-1970’s, extracts of samambaia were reported to decrease the severity of psoriasis.2 In the 1980’s a Spanish company produced a herbal drug from an extract of samambaia and since then it has been a registered as a prescription drug by the Health Ministry of Spain for the treatment of psoriasis. Clinical research with double-blind placebo human trails shows it to be effective for psoriasis, dermatitis and vitiligo ( 3 month treatment). 3-11 Samambaia is an excellent psoriasis herb, eczema herb and dermatitis herb.

Samambaia references:

1. Valetas, J. “Method for preparing a substance having properties against collagen diseases and products obtained.” United States Patent 4,206,222; 1980.

2. Padilla, H.C. “A new agent (hydrophilic fraction of Polypodium leucotomos) for management of psoriasis.” Int. J. Dermatol. 1974; 13(5): 276-282.

3. Mercadal Peyri, O., et al. “Preliminary communication on the treatment of psoriasis with anapsos.” Actas Dermosifiliogr. 1981; 72(9-10):487-494.

4. Capella Perez, M.C., et al. “Double-blind study using ‘anapsos’ 120 mg. in the treatment of psoriasis.” Actas Dermosifiliogr. 1981; 72(9-10): 487-494.

5. Del Pino Gamboa, J., et al. “Comparative study between 120 mg of anapsos and a placebo in 37 psoriasis patients.” Med. Cutan. Ibero. Lat. Am. 1982; 10(3): 203-208.

6. Pineiro Alvarez, B. “2 years personal experience in anapsos treatment of psoriasis in various clinical forms.” Med. Cutan. Ibero. Lat. Am. 1983; 11(1): 65-72.

7. Vargas, J., et al. “Anapsos, an antipsoriatic drug which increases the proportion of suppressor cells in human peripheral blood.” Ann. Immunol. (Paris) 1983; 134C (3): 393-400.

8. Jimenez, D., et al. “Anapsos, an antipsoriatic drug, in atopic dermatitis.” Allergol. Immunopathol. (Madrid) 1987; 15(4): 185-189.

9. Mohammad A. “Vitiligo repigmentation with Anapsos (Polypodium leucotomos).” Int. J. Dermatol. 1989; 28(7): 479.

10. Vasange, M., et al. “The fern Polypodium decumanum, used in the treatment of psoriasis, and its fatty acid constituents as inhibitors of leukotriene B4 formation.” Prostaglandins Leukotrienes Essent. Fatty Acids 1994; 50: 279-284.

11. Tuominen, M., et al. Effects of calaguala and an active principle, adenosine, on platelet activating factor.” Planta Med. 1992; 58(4): 306-310.